News

The European Platform for Neurodegenerative Diseases (EPND) has released its first harmonised biomarker dataset, the ATN dataset, now accessible via the EPND Hub.

Lygature has submitted input to the European Commission’s open consultation on its 2025-2029 Life Sciences Strategy. Our response is now publicly available on the European Commission website. 

Lygature is pleased to announce its official validation as a Research Organization by the European Commission—an important milestone that strengthens our positioning within the European research landscape and opens new avenues for collaboration.

On 19 March 2025, Lygature hosted its stakeholder event, Lygature LIVE, at Villa Jongerius in Utrecht. This year's theme was ‘Impact’, with the afternoon dedicated to exploring how partnerships influence society and global health.

In February, Lygature participated in a series of events co-organized by the Scientific Community for Discovery of Future Medicines (C4D) aimed at establishing networks for discovering new antibiotics.

The Pediatric Praziquantel Consortium, which Lygature proudly coordinates, has achieved a significant milestone with the first administration of its new pediatric treatment to a preschool-aged child in Uganda.

We are happy to announce that Heleen Knottnerus (Policy Officer Advocacy at Diabetes Association Netherlands and EUPATI fellow) and Laurence Maes (Lead Patient Value at Johnson & Johnson Innovative Medicine) have now been confirmed as speakers for Lygature LIVE. Their duo-presentation at Lygature LIVE will focus on boosting the impact of patient involvement in drug discovery.

For almost two decades, Lygature has been building on its experience with managing complex international partnerships. One core expertise of Lygature's is the management of public-private partnerships in the pre-competitive domain such as the Innovative Health Initiative-funded PREDICTOM project.

We are delighted to announce that Chris De Jonghe, Valorization Director at Oncode Institute, has been confirmed as a speaker for Lygature LIVE. Chris will share her insights on the impact of Oncode Institute and highlight the advantages of its connection with Lygature.

Today, 30 January, on World Neglected Tropical Diseases Day, the World Health Organization (WHO) calls upon the global community to unite, act and eliminate neglected tropical diseases (NTDs).

We are excited to announce that Thera Max-Mos has been confirmed as a speaker at Lygature LIVE, which will take place on 19 March 2025.

We are pleased to share the latest edition of the Lygature newsletter, showcasing key achievements and highlights from Q4 2024.

The Lygature coordinated Regulatory Science Network Netherlands (RSNN) will celebrate its 10 year anniversary in 2025. Over the past 10 years the RSNN has successfully brought relevant stakeholders together around important regulatory topics, and has contributed to setting the agenda for regulatory innovation in the Netherlands and internationally.

After 2.5 intense and productive years, Lygature’s involvement in Oncode Accelerator comes to an end. We are confident that the program is now fully equipped to execute its purpose: to accelerate preclinical cancer therapy development. 

"A more high-level definition would be preferred while allowing further specification"